CD30 is required for activation of a unique subset of interleukin- 17A-Producing γδT Cells in innate immunity against mycobacterium bovis bacillus calmette-guérin infection

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3923-3934

  Guo, Ying ^a   Sun, Xun ^a,b   Shibata, Kensuke ^a   Yamada, Hisakata ^a   Muta, Hiromi ^c   Podack, Eckhard R ^d   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD30 ANTIGEN IMMUNOGLOBULIN FUSION PROTEIN; CD30 LIGAND; CD30 MONOCLONAL ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; BOVINE TUBERCULOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMMA DELTA T LYMPHOCYTE; IN VIVO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; ASCITIC FLUID; CD30 LIGAND; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM BOVIS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84884359008     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00887-13     Document Type: Article

References (62)

1. Heilig JS, Tonegawa S. 1986. Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature 322:836-840.
2. Havran WL, Allison JP. 1988. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335:443-445.
3. Hayday AC. 2000. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18:975-1026.
4. Bonneville M, O'Brien RL, Born WK. 2010. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10:467-478.
5. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ, Girardi M, Borst J, Hayday AC, Pennington DJ, Silva-Santos B. 2009. CD27 is a thymic determinant of the balance between interferon-gammaand interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 10:427-436.
6. Jensen KD, Su X, Shin S, Li L, Youssef S, Yamasaki S, Steinman L, Saito T, Locksley RM, Davis MM, Baumgarth N, Chien YH. 2008. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29:90-100.
7. - gamma deltaT cells as fetal thymus-derived innate IL-17 producers. J. Immunol. 181:5940-5947.
8. Turchinovich G, Hayday AC. 2011. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity 35:59-68.
9. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-527.
10. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
11. Kolls JK, Lindén A. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476.
12. Kikly K, Liu L, Na S, Sedgwick JD. 2006. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18: 670-675.
13. Lockhart E, Green AM, Flynn JL. 2006. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662-4669.
14. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, Matsuzaki G. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacilli Calmette-Guerin infection. J. Immunol. 178:3786-3796.
15. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, Kishihara K, Hara H, Nakae S, Iwakura Y, Matsuzaki G. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184:4414-4422.
16. -gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178:4466-4472.
17. Dejima T, Shibata K, Yamada H, Hara H, Iwakura Y, Naito S, Yoshikai Y. 2011. Protective role of innate interleukin-17A-producing γδ T cells in the lung at the early stage of systemic Candidiasis in mice. Infect. Immun. 79:4503-4510.
18. Takeuchi A, Dejima T, Yamada H, Shibata K, Nakamura R, Eto M, Nakatani T, Naito S, Yoshikai Y. 2011. IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer. Eur. J. Immunol. 41: 246-251.
19. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349-1360.
20. Shimozato O, Takeda K, Yagita H, Okumura K. 1999. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem. Biophys. Res. Commun. 256:519-526.
21. Kennedy MK, Willis CR, Armitage RJ. 2006. Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 118:143-152.
22. -) CD3-cells regulate memory responses and lymph-node organization. Nat. Rev. Immunol. 5:655-660.
23. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421-427.
24. - T cells. J. Immunol. 151:2380-2389.
25. Bowen MA, Lee RK, Miragliotta G, Nam SY, Podack ER. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442-449.
26. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. 1995. CD30 and type 2 T helper (Th2) responses. J. Leukoc. Biol. 57:726-730.
27. Bengtsson A. 2001. The role of CD30 in atopic disease. Allergy 56:593-603.
28. Tarkowski M. 2003. Expression and a role of CD30 in regulation of T-cell activity. Curr. Opin. Hematol. 10:267-271.
29. Polte T, Behrendt AK, Hansen G. 2006. Direct evidence for a critical role of CD30 in the development of allergic asthma. J. Allergy Clin. Immunol. 118:942-948.
30. Bengtsson A, Johansson C, Linder MT, Halldén G, van der Ploeg I, Scheynius A. 1995. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J. Leukoc. Biol. 58:683-689.
31. - cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int. Immunol. 9:713-720.
32. Flórido M, Borges M, Yagita H, Appelberg R. 2004. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol. 76:1039-1046.
33. - T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol. 22:72-77.
34. Saraiva M, Smith P, Fallon PG, Alcami A. 2002. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J. Exp. Med. 196:829-839.
35. - T cells via a CD30-dependent mechanism. J. Clin. Invest. 113:310-317.
36. Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, Podack ER, Yoshikai Y. 2008. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. J. Immunol. 181:6316-6327.
37. Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Yoshikai Y. 2010. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. J. Immunol. 185:2222-2230.
38. Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Iwakura Y, Yoshikai Y. 2010. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses. J. Immunol. 185:7671-7680.
39. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
40. Kaufmann SH. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.
41. - T cell-mediated graft-versus-host disease. J. Immunol. 173:2933-2941.
42. Nakamura R, Shibata K, Yamada H, Shimoda K, Nakayama K, Yoshikai Y. 2008. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by γδ T cells. J. Immunol. 181:2071-2075.
43. Inoue T, Yoshikai Y, Matsuzaki G, Nomoto K. 1991. Early appearing gamma/delta-bearing T cells during infection with Calmette Guérin bacillus. J. Immunol. 146:2754-2762.
44. Lafaille JJ, DeCloux A, Bonneville M, Takagaki Y, Tonegawa S. 1989. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J. joining. Cell 59:859-870.
45. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 89:12013-12017.
46. - T cells display enhanced antitumor immunity. Blood 114:596-599.
47. - T cells in nasopharyngeal carcinoma. J. Transl. Med. 9:189. doi:10.1186/1479-5876-9-189.
48. - T cells play a role in early protection against infection by Listeria monocytogenes in a CD30L-dependent manner. Microbiol. Immunol. 55:645-656.
49. Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hübinger G, KieffE, Herrmann F, Leutz A, Gruss HJ. 1996. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc. Natl. Acad. Sci. U. S. A. 93:14053-14058.
50. Lee SY, Lee SY, Kandala G, Liou ML, Liou HC, Choi Y. 1996. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc. Natl. Acad. Sci. U. S. A. 93:9699-9703.
51. Duckett CS, Gedrich RW, Gilfillan MC, Thompson CB. 1997. Induction of nuclear factor kappa B by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17:1535-1542.
52. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. 2009. Interleukin- 17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-330.
53. Mokuno Y, Matsuguchi T, Takano M, Nishimura H, Washizu J, Ogawa T, Takeuchi O, Akira S, Nimura Y, Yoshikai Y. 2000. Expression of toll-like receptor 2 on gamma delta T cells bearing invariant Vγ6/Vδ1 induced by Escherichia coli infection in mice. J. Immunol. 165:931-940.
54. Shibata K, Yamada H, Sato T, Dejima T, Nakamura M, Ikawa T, Hara H, Yamasaki S, Kageyama R, Iwakura Y, Kawamoto H, Toh H, Yoshikai Y. 2011. Notch-Hes1 pathway is required for the development of IL-17-producing γδ T cells. Blood 118:586-593.
55. González-García S, García-Peydró M, Martín-Gayo E, Ballestar E, Esteller M, Bornstein R, de la Pompa JL, Ferrando AA, Toribio ML. 2009. CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL- 7R{alpha} gene expression in early human thymopoiesis and leukemia. J. Exp. Med. 206:779-791.
56. -CD3+ inducer cells: evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J. Immunol. 174:6686-6691.
57. Hou L, Jie Z, Desai M, Liang Y, Soong L, Wang T, Sun J. 2013. Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J. Immunol. 190:621-629.
58. Nandi D, Allison JP. 1991. Phenotypic analysis and gamma delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol. 147:1773-1778.
59. - lymphocytes are derived from a common distinct lineage. J. Immunol. 151:4523-4527.
60. Zeng X, Wei YL, Huang J, Newell EW, Yu H, Kidd BA, Kuhns MS, Waters RW, Davis MM, Weaver CT, Chien YH. 2012. γδ T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response. Immunity 37:524-534. doi:10.1016/j.immuni.2012.06.011.
61. Malhotra N, Narayan K, Cho OH, Sylvia KE, Yin C, Melichar H, Rashighi M, Lefebvre V, Harris JE, Berg LJ, Kang J, Immunological Genome Project Consortium. 2013. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38:681-693. doi:10.1016/j.immuni.2013.01.010.
62. Gopal R, Lin Y, Obermajer N, Slight S, Nuthalapati N, Ahmed M, Kalinski P, Khader SA. 2012. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur. J. Immunol. 42:364-373.